Literature DB >> 26869640

Early versus late surgical intervention or medical management for infective endocarditis: a systematic review and meta-analysis.

Mahesh Anantha Narayanan1, Toufik Mahfood Haddad1, Andre C Kalil2, Arun Kanmanthareddy3, Rakesh M Suri4, George Mansour1, Christopher J Destache5, Janani Baskaran6, Aryan N Mooss3, Tammy Wichman7, Lee Morrow7, Renuga Vivekanandan8.   

Abstract

OBJECTIVE: Infective endocarditis is associated with high morbidity and mortality and optimal timing for surgical intervention is unclear. We performed a systematic review and meta-analysis to compare early surgical intervention with conservative therapy in patients with infective endocarditis.
METHODS: PubMed, Cochrane, EMBASE, CINAHL and Google-scholar databases were searched from January 1960 to April 2015. Randomised controlled trials, retrospective cohorts and prospective observational studies comparing outcomes between early surgery at 20 days or less and conservative management for infective endocarditis were analysed.
RESULTS: A total of 21 studies were included. OR of all-cause mortality for early surgery was 0.61 (95% CI 0.50 to 0.74, p<0.001) in unmatched groups and 0.41 (95% CI 0.31 to 0.54, p<0.001) in the propensity-matched groups (matched for baseline variables). For patients who had surgical intervention at 7 days or less, OR of all-cause mortality was 0.61 (95% CI 0.39 to 0.96, p=0.034) and in those who had surgical intervention within 8-20 days, the OR of mortality was 0.64 (95% CI 0.48 to 0.86, p=0.003) compared with conservative management. In propensity-matched groups, the OR of mortality in patients with surgical intervention at 7 days or less was 0.30 (95% CI 0.16 to 0.54, p<0.001) and in the subgroup of patients who underwent surgery between 8 and 20 days was 0.51 (95% CI 0.35 to 0.72, p<0.001). There was no significant difference in in-hospital mortality, embolisation, heart failure and recurrence of endocarditis between the overall unmatched cohorts.
CONCLUSION: The results of our meta-analysis suggest that early surgical intervention is associated with significantly lower risk of mortality in patients with infective endocarditis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26869640     DOI: 10.1136/heartjnl-2015-308589

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  28 in total

1.  Determinants and consequences of positive valve culture when cardiac surgery is performed during the acute phase of infective endocarditis.

Authors:  P Fillâtre; A Gacouin; M Revest; A Maamar; S Patrat-Delon; E Flécher; O Fouquet; N Lerolle; J-P Verhoye; Y Le Tulzo; Pierre Tattevin; J-M Tadié
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-26       Impact factor: 3.267

2.  Valvular disease: Benefit of early surgery for infective endocarditis.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2016-03-03       Impact factor: 32.419

3.  What's new in surgical treatment of infective endocarditis?

Authors:  Thierry Carrel; Lars Englberger; Jukka Takala
Journal:  Intensive Care Med       Date:  2016-09-23       Impact factor: 17.440

4.  [A challenging decision-making-process pro or con surgical heart valve replacement in a case of long-term non-adherence : A case report].

Authors:  René Florian Oswald; H Christof Müller-Busch
Journal:  Wien Med Wochenschr       Date:  2018-02-15

Review 5.  Blood culture negative endocarditis in the modern era of 16S rRNA sequencing.

Authors:  Rebecca Godfrey; Sally Curtis; William Hk Schilling; P Rachael James
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

6.  Risk Factors for In-Hospital Mortality in Infective Endocarditis.

Authors:  Ana Marques; Inês Cruz; Daniel Caldeira; Sofia Alegria; Ana Catarina Gomes; Ana Luísa Broa; Isabel João; Hélder Pereira
Journal:  Arq Bras Cardiol       Date:  2020-01       Impact factor: 2.000

Review 7.  Infective endocarditis: trends, surgical outcomes, and controversies.

Authors:  Mahbub Jamil; Ibrahim Sultan; Thomas G Gleason; Forozan Navid; Michael A Fallert; Matthew S Suffoletto; Arman Kilic
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

8.  Bivalirudin versus heparin in percutaneous coronary intervention-a systematic review and meta-analysis of randomized trials stratified by adjunctive glycoprotein IIb/IIIa strategy.

Authors:  Mahesh Anantha-Narayanan; Dixitha Anugula; Nagarjuna R Gujjula; Yogesh N V Reddy; Janani Baskaran; Manu Kaushik; Venkata M Alla; Ganesh Raveendran
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

9.  Impact of Valve Culture Positivity on Prognosis in Patients with Infective Endocarditis Who Underwent Valve Surgery.

Authors:  Jinnam Kim; Jung Ho Kim; Hi Jae Lee; Se Ju Lee; Ki Hyun Lee; Eun Hwa Lee; Yae Jee Baek; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Seung Hyun Lee; Jun Yong Choi; Joon-Sup Yeom
Journal:  Infect Dis Ther       Date:  2022-04-30

10.  Prognostic value of D-dimer for adverse outcomes in patients with infective endocarditis: an observational study.

Authors:  Ying-Wen Lin; Mei Jiang; Xue-Biao Wei; Jie-Leng Huang; Zedazhong Su; Yu Wang; Ji-Yan Chen; Dan-Qing Yu
Journal:  BMC Cardiovasc Disord       Date:  2021-06-05       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.